Acquired haemophilia A and late development of secondary autoimmune disorders, evidences from a single-centre observational study.
暂无分享,去创建一个
[1] R. Greil,et al. Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study. , 2015, Blood.
[2] F. Pellegrini,et al. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). , 2012, Blood.
[3] F. Pellegrini,et al. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. , 2012, Blood.
[4] J. Esser,et al. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2) , 2012, Journal of thrombosis and haemostasis : JTH.
[5] T. Baglin,et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. , 2007, Blood.
[6] R. Liesner,et al. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation , 2006, British journal of haematology.
[7] F. Baudo,et al. Acquired hemophilia: a critical bleeding syndrome. , 2004, Haematologica.
[8] J. Wan,et al. Inhibitors against factor VIII in patients with cancer , 2001, Cancer.
[9] C. Hay. 1 Acquired haemophilia , 1998 .